English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

1. Ellen and Martin Prosserman Centre for Neuromuscular Diseases, Division of Neurology, Department of Medicine, University Health Network, University of Toronto, Toronto, Canada; 2. Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA; 3. Department of Neurology, Johns Hopkins Medicine, Baltimore, MD, USA; 4. Department of Neurology, University of Minnesota, Minneapolis, MN, USA; 5. CSL Behring, King of Prussia, PA, USA; 6. Department of Allergy and Clinical Immunology, Division of Asthma, Allergy and Lung Biology, King’s College London, King’s Health Partners, King’s College Hospital NHS Foundation Trust, School of Medicine, London, UK; 7. Patient Representative on GAIN Medical Advisory Board, Sleaford, Lincolnshire, UK; 8. Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia

Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy – Neurologist, Nursing and Patient Perspectives